NCT00806936View on ClinicalTrials.gov

Observational Study to Investigate the Efficacy and Safety of Human Insulin or Insulin Analogue Treatments in Type 2 Diabetes Subjects

CompletedOBSERVATIONAL
Enrollment

4,847

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

human insulin

Any kind of human insulin administered at the discretion of the physician

DRUG

insulin analogue

Any kind of insulin analogue administered at the discretion of the physician

Trial Locations (1)

100004

Novo Nordisk Investigational Site, Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY